Evidence map›Paper›PMID 39043156›Full record

ArticleJournal of geriatric psychiatry and neurology2025

Two-Year Longitudinal Outcomes of Subjective Cognitive Decline in Hispanics Compared to Non-hispanic Whites.

Carolina Boza-Calvo, Arline Faustin, Yian Zhang, Anthony Q Briggs, Mark A Bernard, Omonigho M Bubu, Julia A Rao, Lindsey Gurin, Sakina Ouedraogo Tall, Ricardo S Osorio and 3 more

Abstract readComparative Study
In one paragraph

Article in Journal of geriatric psychiatry and neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carolina Boza-CalvoCentro de Investigación en Hematología y Trastornos Afines (CIHATA), Universidad de Costa Rica, San José, Costa Rica.ORCID 0000-0002-2048-0668
Arline FaustinNYU Alzheimer's Disease Research Center, NY, USA.
Yian ZhangNYU Alzheimer's Disease Research Center, NY, USA.
Anthony Q BriggsNYU Alzheimer's Disease Research Center, NY, USA.ORCID 0000-0002-9459-5214
Mark A BernardNYU Alzheimer's Disease Research Center, NY, USA.ORCID 0000-0003-2523-9782
Omonigho M BubuNYU Alzheimer's Disease Research Center, NY, USA.
Julia A RaoNYU Alzheimer's Disease Research Center, NY, USA.
Lindsey GurinNYU Alzheimer's Disease Research Center, NY, USA.
Sakina Ouedraogo TallNYU Alzheimer's Disease Research Center, NY, USA.
Ricardo S OsorioNYU Alzheimer's Disease Research Center, NY, USA.
Karyn MarshNYU Alzheimer's Disease Research Center, NY, USA.
Yongzhao ShaoNYU Alzheimer's Disease Research Center, NY, USA.
Arjun V MasurkarNYU Alzheimer's Disease Research Center, NY, USA.

Funding

PSYCHOSOCIAL COREP30AG008051 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI RUSINEK, HENRY · 1990 to 2019
$36.1M
Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-AmericansR01AG082278 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OMONIGHO A MICHAEL Bubu · 2023 to 2026
$6.9M
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacksRF1AG083975 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI OMONIGHO A MICHAEL Bubu, Korey Kam · 2023 to 2026
$4.2M
The mediating role of Slow Wave Sleep and Vascular Risk Factors on Alzheimer Disease related disparity between African-Americans and non-Hispanic WhitesK23AG068534 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUBU, OMONIGHO A MICHAEL · 2021 to 2025
$958k
NIA NIH HHS K23 AG068534NIA NIH HHS L30 AG064670NIA NIH HHS P30 AG008051NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG082278NIA NIH HHS RF1 AG083975NIOSH CDC HHS U01 OH012486
6 · The paper itself

Abstract

backgroundSubjective cognitive decline (SCD), considered a preclinical dementia stage, is less understood in Hispanics, a high-risk group for dementia. We investigated SCD to mild cognitive impairment (MCI) progression risk, as well as baseline and longitudinal features of depressive symptoms, SCD complaints, and objective cognitive performance among Hispanics compared to non-Hispanic Whites (NHW).

methodsHispanic (n = 23) and NHW (n = 165) SCD participants were evaluated at baseline and 2-year follow-up. Evaluations assessed function, depressive symptoms, SCD, and objective cognitive performance.

resultsHispanics were at increased risk of progression to MCI (OR: 6.10, 95% CI 1.09-34.20,

Indexed as

Cognitive DysfunctionDepressionDisease ProgressionHispanic or LatinoWhiteAgedAged, 80 and overFemaleHumansLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsAlzheimer’s diseasecognitionhispanic ethnicitylongitudinal studiesmild cognitive impairmentsubjective cognitive decline

Identifiers

PMID39043156
PMCPMC12856748

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.